Navigation Links
Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association
Date:11/10/2008

ur kit designed to detect Hp2-2 Diabetes, once it is cleared by the FDA, and its anticipated widespread availability bode well for its acceptance as an important tool in the detection of cardiovascular risk in diabetic patients. In turn, our test can help physicians make better treatment decisions for patients with Hp2-2 Diabetes."

At present, the haptoglobin genotype test is offered by ARUP Laboratories. A network of participating reference laboratories may forward samples to ARUP. Physicians interested in haptoglobin testing can call ARUP's 24 hour a day customer service line (800-522-2787) to obtain information on how to submit a blood sample for testing (Refer to ARUP test number 0040116).

About the Studies

In the prospective study called ICARE, 2,241 individuals with diabetes mellitus age 55 or over from 47 primary-care clinics in Israel underwent haptoglobin genotype testing and were followed for three years to track heart attack (myocardial infarction), stroke and death (cardiovascular and all cause). The study included 708 individuals with the Hp 2-2 genotype and 1,533 with one of the other two Hp genotypes (1-1 and 2-1). While baseline measurements showed no difference between the two groups in diabetes characteristics (HbA1c, duration), over the next three years, cardiovascular death was five-fold higher in the Hp 2-2 group (p=0.0001) and non-fatal MI increased by more than 50 percent (p=0.068). The differences in mortality were not affected by adjustment for diabetes characteristics or conventional cardiovascular risk factors.

The second study, another sub-study from ICARE, followed the results of tight glycemic control for a subgroup of patients during the three-year follow-up. After stratification of participants to those with an average HbA1c of above or below 7.0, results demonstrated that only those individuals who had the Hp2-2 genotype and who maintained strict glycemic control showed a reduction in the incidence of MI.
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Synvista Therapeutics Posts Letter to Stockholders on Web Site
2. Vista Partners Initiates Coverage on Synvista Therapeutics, Inc. (AMEX: SYI)
3. Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure
4. Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference
5. Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales
6. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
7. Synvista Therapeutics to Present at the 10th Annual BIO CEO & Investor Conference
8. Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis
9. Synvista Therapeutics to be Featured on Wallst.net
10. Synvista Therapeutics to Present at the BIO InvestorForum 2007
11. MGuard(TM), InspireMDs Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... DIEGO, Dec. 15 Aethlon Medical, Inc. ... Dr. Jeff Schorey and Dr. Wayne Comper ... Exosome Sciences, Inc. (ESI). Both Dr. Schorey and ... field. ESI, a wholly owned subsidiary of Aethlon ... that the Hemopurifier®, a medical device being advanced ...
(Date:12/15/2009)... The Center for Business Intelligence (CBI), a ... announce the full agenda for the ... . The forum will take place at ... ,, Over 1,500 senior-level Finance, Accounting, Audit ... event since its inception, and this year,s ...
(Date:12/14/2009)... OAKS, Calif., Dec. 14 Array BioPharma ... AMGN ) today announced that they entered ... to Array,s small-molecule glucokinase activator program, including ARRY-403, ... trial in patients with Type 2 diabetes. ... Array will receive an upfront payment of $60 ...
(Date:12/14/2009)... Dec. 14 Boston Scientific Corporation (NYSE: ... public offering of $2 billion aggregate principal amount of ... The public offering consists of $850 million of ... 6.00 percent notes due January 2020 and $300 million ... Scientific plans to use the net proceeds for general ...
Breaking Biology Technology:Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 2Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 4Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 5CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3
... set off marginally legal fireworks, I was feeling a little ... mobile phone was powered off most of the weekend. Here ... I felt anything but independent of my technologies. , ,Ignoring ... comes with a penalty of sorting through an over-loaded ...
... issues of connectivity and compatibility between clinicians dealing with ... proprietary technologies. This splintering of technology in turn ... it difficult to consider a patients entire health record ... ,A new attempt to fill this need has come ...
... Businesses that manufacture FDA-regulated products are not the ... U.S. Food & Drug Administration at any time. ... humans) and nonclinical laboratories that conduct animal, plant ... drugs, biologics, or devices. , ,FDA enforces many ...
Other Biology Technology:Declaring independence from technology (sort of) 2Declaring independence from technology (sort of) 3TeraMedica unveils electronic health record solution 2Who's that knocking at the door? Preparing for an FDA inspection 2Who's that knocking at the door? Preparing for an FDA inspection 3Who's that knocking at the door? Preparing for an FDA inspection 4
(Date:12/14/2009)... laparoscopy is in preventing some of the stresses of open ... blood flow and organ dysfunction. Laparoscopy is a type of ... , By adding another gas to the carbon ... at Duke University Medical Center have found they can preserve ... gas ethyl nitrite (ENO) helped to open blood vessels and ...
(Date:12/13/2009)... Yale University researchers has used nanosensors to measure ... time. Their findings, which appear December 13 in ... , could dramatically simplify the way physicians test ... , The teamled by Mark Reed, Yale,s ... and Tarek Fahmy, an associate professor of biomedical ...
(Date:12/11/2009)... ROUGE, LAKeeping with the global "green" trend, ... education lessons to enhance students, science knowledge. ... into the curriculum raises not just science ... scores in other subject areas. Naturally, educators ... integrate these relevant lessons into the classroom ...
Breaking Biology News(10 mins):Gas improves blood flow and organ status during minimally invasive surgery 2Scientists use nanosensors for first time to measure cancer biomarkers in blood 2Students learn environmental stewardship, improve science scores 2DNA Helps Reunite Children With Their Families 9665 1DNA Helps Reunite Children With Their Families 9665 2DNA Helps Reunite Children With Their Families 9665 3eHealth interventions need to be continuously evaluated 55063 1eHealth interventions need to be continuously evaluated 55063 2JNCI news brief 3A High serum insulin levels and risk of prostate cancer 55059 1
... Pharma, Inc., have announced the Food and Drug Administration's ... that incorporates a biodegradable technology developed at the university. ... of biomaterials from permanent prosthetic replacements toward regenerative medicine, ... and are then resorbed. , The device consists ...
... the Columbia River may be declining due to the ... and polychlorinated biphenyls in their bodies, according to new ... The research by Carl Schreck and Grant Feist, biologists ... in the journals Environmental Health Perspectives and Archives of ...
... and in most mammals, males are usually more aggressive and ... like testosterone, for male behavior such as aggression. But maybe ... also has a genetic basis, according to new research on ... "The differences in sex chromosomes, XX versus XY, are ...
Other Biology News:FDA approves first medical device using rutgers biomaterial 2Contaminants linked to sturgeon decline in Columbia river 2Sex chromosome genes influence aggression andmaternal behavior, say UVa researchers 2
albumin from bovine serum (BSA), Alexa Fluor® 647 conjugate...
albumin from bovine serum (BSA), BODIPY® FL conjugate...
albumin from bovine serum (BSA), tetramethylrhodamine conjugate...
... (human, bovine, porcine, rat) ... receptor antagonist. This carboxy-terminal VIP ... twofold more potent than any ... Storage: ...
Biology Products: